Redhill Biopharma
RDHL
#9801
Rank
โ‚ฌ8.84 M
Marketcap
6,91ย โ‚ฌ
Share price
6.11%
Change (1 day)
-11.06%
Change (1 year)

Revenue for Redhill Biopharma (RDHL)

Revenue in 2023 (TTM): โ‚ฌ34.74 Million

According to Redhill Biopharma's latest financial reports the company's current revenue (TTM ) is โ‚ฌ33.87 Million. In 2022 the company made a revenue of โ‚ฌ57.61 Million a decrease over the revenue in the year 2021 that were of โ‚ฌ75.72 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Redhill Biopharma from 2012 to 2023

Annual revenue

Year Revenue Change
2023 (TTM) โ‚ฌ34.74 M-39.7%
2022 โ‚ฌ57.61 M-23.92%
2021 โ‚ฌ75.72 M44.72%
2020 โ‚ฌ52.32 M831.74%
2019 โ‚ฌ5.61 M-23.15%
2018 โ‚ฌ7.3 M118.82%
2017 โ‚ฌ3.33 M3377.95%
2016 โ‚ฌ0.09 M3399.65%
2015 โ‚ฌ0 M-99.95%
2014 โ‚ฌ5.76 M66270.22%
2013 โ‚ฌ0 M-28.16%
2012 โ‚ฌ0.01 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚ฌ50.70 B 149,591.25%๐Ÿ‡ซ๐Ÿ‡ท France
โ‚ฌ59.21 B 174,690.88%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ38.14 B 112,510.73%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚ฌ0.57 B 1,608.85%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
โ‚ฌ15.43 B 45,472.81%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel